Combination therapy • P2 data • Clinical • PD(L)-1 Biomarker • IO biomarker • Pan tumor
|
HER-2 (Human epidermal growth factor receptor 2)
|
PD-L1 expression • HER-2 negative
|
Oncomap™ ExTra test • Xerna TME™ Panel
|
paclitaxel • Trodelvy (sacituzumab govitecan-hziy) • navicixizumab (OMP-305B83)